Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

Lymphocytes, a type of immune cell, are crucial for wound healing as they help remodel damaged areas and reduce inflammation.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.